The toxicity of quartz is largely related to its surface properties, and can be reduced by aluminium.' 2Aluminium lactate in itself has no biological activity on lung tissue and its action is through binding to the surface of quartz so masking its chemical functions. The amounts of aluminium required to reduce disease in our earlier studies2I were well below the average amount of aluminium impurities in commercial table salt or in one tablet of gastric antacid. The reduction of the biological activities of quartz by aluminium and other surface active compounds has been documented in cell culture4 and in vivo, when the quartz was treated before exposure.3 In exploring further the activity of aluminium inhalation, we recently tested its power to alter the silicosis process one year after disease was recognised by standard chest radiography, which would be a realistic intervention time in the human condition. We found no significant effect of aluminium treatment at monthly intervals for one year. We therefore extended the study for another two years with treatments at weekly intervals.
Materials and methods

ANIMAIS
Fourteen of the 24 sheep that were originally exposed to silica developed silicosis as determined by a definitely abnormal chest radiograph (category 1 or above in the International Labour Organisation (ILO) classification of radiographs).' The 14 sheep exposed to silica had an abnormal chest radiograph of ILO category 1 or above after three years of 100 mg Minusil-5 in 100 ml saline intratracheal injections at 10 day intervals. Minusil-5 silica particles have been well characterized, 99 however, mortality was significantly higher in the silicotic sheep than in the controls (P < 0-05, figure) .
The severity and progression of the disease was evaluated by chest radiograph and lung function tests. The control sheep had normal radiographs whereas those in the two silicotic groups had on the average an ILO concise category 2 disease, which did not change significantly over the three year period of study (figure) . Similarly the altered lung function tests in the silicotic sheep were not significantly modified by aluminium treatment (figure). The lung lavage previously reported in the silicotic sheep4 showed that the alveolitis with characteristics of cytotoxicity, lung matrix damage, and fibrogenicity had regressed substantially after the end of exposure, between months 36 and 48, but thereafter, remained significantly changed in activity above the controls in most variables. These lung lavage variables were also unaffected by three years of aluminium treatment (figure).
Discussion
This paper reports on the influence of three years of treatment with aluminium aerosol on silicosis radiographically detected in the sheep model. The disease was induced at a relatively low level of exposure as witnessed by the longer interval between exposures and by the longer exposure time needed to induce silicosis than in earlier studies in our laboratory. 2 10 The disease reproduced in the sheep had the fundamental characteristics of human simple nodular silicosis, as documented in earlier studies.28-10 The disease produced ILO concise category 2 radiographic opacities, restrictive lung function alterations, and modifications on lung lavage consistent with silica induced alveolitis. Treatment was started one year after exposure had ended. We found no significant improvement of the silicotic condition on any of the radiographic, functional, or lung lavage variables.
In earlier studies of aluminium treatment of silicosis,'81-011 we had documented a significant inhibition of toxicity of silica, when the quartz was treated before exposure and when treatment was started early after exposure. In this study, treatment was started one year after initial radiographic recognition of silicosis, which would constitute a likely simulation of the human condition. The serial measures of radiographic score of disease, the pulmonary function tests, and the analyses of lung ravages were not significantly changed by the aluminium treatments. For the clinician, these data are disappointing as it had been hoped that aluminium treatment would be of therapeutic interest at least in the early stages of the disease. These results are clear and are further supported by clearance studies'2 that documented the half life of quartz coated with aluminium lactate inhaled for five months, compared with that of native quartz. They support the conclusions of an earlier study in humans. ' The absence of effect on the clearance of quartz and on the disease induced could be related to the chosen concentration and treatment intervals (all possibilities have not been tested) or more likely because aluminium lactate may not come into contact with the quartz particles, already covered by surfactant, phagocytosed by macrophages, and migrated into the interstitium.
In conclusion, treatment of silicosis with aluminium aerosol after radiographic recognition of disease did not alter the disease process. 
